中国末梢采血操作共识

2018-06-12 中国医师协会检验医师分会 中华医学杂志.2018.98(22):1752-1760.·

静脉血和末梢血为临床常用血液检测标本。随着检验医学技术现代化、微量化、便捷化的不断发展和日益完善,末梢血的应用也越来越广泛。由于儿童自主配合依从性差、血管纤细,在静脉血标本采集过程中,相比成人采血成功率低、并发症发生率更高,因此末梢血采集在儿科临床工作中占有不可或缺的地位。与静脉血相比,末梢血影响因素较多,如采集过程操作不规范,易导致检测结果变异或不准确,因此规范末梢采血操作至关重要。目前我国缺乏

中文标题:

中国末梢采血操作共识

发布日期:

2018-06-12

简要介绍:

静脉血和末梢血为临床常用血液检测标本。随着检验医学技术现代化、微量化、便捷化的不断发展和日益完善,末梢血的应用也越来越广泛。由于儿童自主配合依从性差、血管纤细,在静脉血标本采集过程中,相比成人采血成功率低、并发症发生率更高,因此末梢血采集在儿科临床工作中占有不可或缺的地位。与静脉血相比,末梢血影响因素较多,如采集过程操作不规范,易导致检测结果变异或不准确,因此规范末梢采血操作至关重要。目前我国缺乏末梢采血操作的统一标准和规范,国外的相关指南又难以符合我国的实际需求。为规范我国末梢采血操作流程,中国医师协会检验医师分会儿科疾病检验医学专家委员会和世界华人检验与病理医师协会共同制定了本共识,旨在提供中国末梢血液标本规范化采集操作的参考依据,提高末梢血标本检验质量。 

拓展指南:采血相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国末梢采血操作共识)] GetToolGuiderByIdResponse(projectId=1, id=fb6791c001603ab3, title=中国末梢采血操作共识, enTitle=, guiderFrom=中华医学杂志.2018.98(22):1752-1760.·, authorId=null, author=, summary=静脉血和末梢血为临床常用血液检测标本。随着检验医学技术现代化、微量化、便捷化的不断发展和日益完善,末梢血的应用也越来越广泛。由于儿童自主配合依从性差、血管纤细,在静脉血标本采集过程中,相比成人采血成功率低、并发症发生率更高,因此末梢血采集在儿科临床工作中占有不可或缺的地位。与静脉血相比,末梢血影响因素较多,如采集过程操作不规范,易导致检测结果变异或不准确,因此规范末梢采血操作至关重要。目前我国缺乏, cover=, journalId=null, articlesId=null, associationId=1260, associationName=中国医师协会检验医师分会, associationIntro=, copyright=0, guiderPublishedTime=Tue Jun 12 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>静脉血和末梢血为临床常用血液检测标本。随着检验医学技术现代化、微量化、便捷化的不断发展和日益完善,末梢血的应用也越来越广泛。由于儿童自主配合依从性差、血管纤细,在静脉血标本采集过程中,相比成人采血成功率低、并发症发生率更高,因此末梢血采集在儿科临床工作中占有不可或缺的地位。与静脉血相比,末梢血影响因素较多,如采集过程操作不规范,易导致检测结果变异或不准确,因此规范末梢采血操作至关重要。目前我国缺乏末梢采血操作的统一标准和规范,国外的相关指南又难以符合我国的实际需求。为规范我国末梢采血操作流程,中国医师协会检验医师分会儿科疾病检验医学专家委员会和世界华人检验与病理医师协会共同制定了本共识,旨在提供中国末梢血液标本规范化采集操作的参考依据,提高末梢血标本检验质量。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>采血</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=14d1d1c00106926d" title="2014 AAGBI安全指南:动脉导管采血:预防低血糖患者脑损伤" target=_blank>2014 AAGBI安全指南:动脉导管采血:预防低血糖患者脑损伤</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d18d01c000ea5049" title="2010 WHO采血指南:静脉采血的最佳操作(英文版)" target=_blank>2010 WHO采血指南:静脉采血的最佳操作(英文版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=a444d1c000ea4965" title="2010 世界卫生组织采血指南:静脉采血的最佳操作(中文版)" target=_blank>2010 世界卫生组织采血指南:静脉采血的最佳操作(中文版)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E9%87%87%E8%A1%80" target=_blank>有关采血更多指南</a></ul>, tagList=[TagDto(tagId=76351, tagName=末梢采血)], categoryList=[CategoryDto(categoryId=69, categoryName=检验, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12080, appHits=289, showAppHits=0, pcHits=6081, showPcHits=7380, likes=100, shares=12, comments=10, approvalStatus=1, publishedTime=Thu Jun 14 22:30:39 CST 2018, publishedTimeString=2018-06-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Jun 14 22:30:39 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 21:20:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国末梢采血操作共识)])
中国末梢采血操作共识
下载请点击:
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=954067, encodeId=253595406e71, content=有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210330/89ac79da9e2b46c49dd38698f891938b/15793a72df234d0090cbd82601754957.jpg, createdBy=a3f15387118, createdName=ms5000002143624482, createdTime=Mon Apr 05 23:37:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324483, encodeId=9c5732448310, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jun 15 22:50:08 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324367, encodeId=67d232436e64, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Jun 15 08:42:49 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324357, encodeId=cf7f32435e10, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jun 15 08:19:59 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324334, encodeId=f2993243349f, content=值得探讨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Fri Jun 15 07:45:18 CST 2018, time=2018-06-15, status=1, ipAttribution=)]
    2021-04-05 ms5000002143624482

    有收获

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=954067, encodeId=253595406e71, content=有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210330/89ac79da9e2b46c49dd38698f891938b/15793a72df234d0090cbd82601754957.jpg, createdBy=a3f15387118, createdName=ms5000002143624482, createdTime=Mon Apr 05 23:37:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324483, encodeId=9c5732448310, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jun 15 22:50:08 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324367, encodeId=67d232436e64, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Jun 15 08:42:49 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324357, encodeId=cf7f32435e10, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jun 15 08:19:59 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324334, encodeId=f2993243349f, content=值得探讨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Fri Jun 15 07:45:18 CST 2018, time=2018-06-15, status=1, ipAttribution=)]
    2018-06-15 大爰

    学习了谢谢分享!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=954067, encodeId=253595406e71, content=有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210330/89ac79da9e2b46c49dd38698f891938b/15793a72df234d0090cbd82601754957.jpg, createdBy=a3f15387118, createdName=ms5000002143624482, createdTime=Mon Apr 05 23:37:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324483, encodeId=9c5732448310, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jun 15 22:50:08 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324367, encodeId=67d232436e64, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Jun 15 08:42:49 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324357, encodeId=cf7f32435e10, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jun 15 08:19:59 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324334, encodeId=f2993243349f, content=值得探讨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Fri Jun 15 07:45:18 CST 2018, time=2018-06-15, status=1, ipAttribution=)]
    2018-06-15 龙胆草

    学习谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=954067, encodeId=253595406e71, content=有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210330/89ac79da9e2b46c49dd38698f891938b/15793a72df234d0090cbd82601754957.jpg, createdBy=a3f15387118, createdName=ms5000002143624482, createdTime=Mon Apr 05 23:37:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324483, encodeId=9c5732448310, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jun 15 22:50:08 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324367, encodeId=67d232436e64, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Jun 15 08:42:49 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324357, encodeId=cf7f32435e10, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jun 15 08:19:59 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324334, encodeId=f2993243349f, content=值得探讨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Fri Jun 15 07:45:18 CST 2018, time=2018-06-15, status=1, ipAttribution=)]
    2018-06-15 1dd8c52fm63(暂无匿称)

    了解了解.继续关注

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=954067, encodeId=253595406e71, content=有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210330/89ac79da9e2b46c49dd38698f891938b/15793a72df234d0090cbd82601754957.jpg, createdBy=a3f15387118, createdName=ms5000002143624482, createdTime=Mon Apr 05 23:37:34 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324483, encodeId=9c5732448310, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Jun 15 22:50:08 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324367, encodeId=67d232436e64, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Jun 15 08:42:49 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324357, encodeId=cf7f32435e10, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Fri Jun 15 08:19:59 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324334, encodeId=f2993243349f, content=值得探讨, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Fri Jun 15 07:45:18 CST 2018, time=2018-06-15, status=1, ipAttribution=)]
    2018-06-15 易水河

    值得探讨

    0